375 related articles for article (PubMed ID: 14726483)
1. Nuclear antisense effects in cyclophilin A pre-mRNA splicing by oligonucleotides: a comparison of tricyclo-DNA with LNA.
Ittig D; Liu S; Renneberg D; Schümperli D; Leumann CJ
Nucleic Acids Res; 2004; 32(1):346-53. PubMed ID: 14726483
[TBL] [Abstract][Full Text] [Related]
2. Target selection for antisense oligonucleotide induced exon skipping in the dystrophin gene.
Errington SJ; Mann CJ; Fletcher S; Wilton SD
J Gene Med; 2003 Jun; 5(6):518-27. PubMed ID: 12797117
[TBL] [Abstract][Full Text] [Related]
3. Towards a therapeutic inhibition of dystrophin exon 23 splicing in mdx mouse muscle induced by antisense oligoribonucleotides (splicomers): target sequence optimisation using oligonucleotide arrays.
Graham IR; Hill VJ; Manoharan M; Inamati GB; Dickson G
J Gene Med; 2004 Oct; 6(10):1149-58. PubMed ID: 15386737
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of HIV-1 multiplication by antisense U7 snRNAs and siRNAs targeting cyclophilin A.
Liu S; Asparuhova M; Brondani V; Ziekau I; Klimkait T; Schümperli D
Nucleic Acids Res; 2004; 32(12):3752-9. PubMed ID: 15254276
[TBL] [Abstract][Full Text] [Related]
5. Antisense-mediated exon skipping to shift alternative splicing to treat cancer.
Wan J
Methods Mol Biol; 2012; 867():201-8. PubMed ID: 22454063
[TBL] [Abstract][Full Text] [Related]
6. Optimizing splice-switching oligomer sequences using 2'-O-methyl phosphorothioate chemistry.
Adkin C; Fletcher S; Wilton SD
Methods Mol Biol; 2012; 867():169-88. PubMed ID: 22454061
[TBL] [Abstract][Full Text] [Related]
7. RNase H1-Dependent Antisense Oligonucleotides Are Robustly Active in Directing RNA Cleavage in Both the Cytoplasm and the Nucleus.
Liang XH; Sun H; Nichols JG; Crooke ST
Mol Ther; 2017 Sep; 25(9):2075-2092. PubMed ID: 28663102
[TBL] [Abstract][Full Text] [Related]
8. Induction of cryptic pre-mRNA splice-switching by antisense oligonucleotides.
Ham KA; Keegan NP; McIntosh CS; Aung-Htut MT; Zaw K; Greer K; Fletcher S; Wilton SD
Sci Rep; 2021 Jul; 11(1):15137. PubMed ID: 34302060
[TBL] [Abstract][Full Text] [Related]
9. Factors determining the efficacy of nuclear delivery of antisense oligonucleotides by gold nanoparticles.
Liu Y; Franzen S
Bioconjug Chem; 2008 May; 19(5):1009-16. PubMed ID: 18393455
[TBL] [Abstract][Full Text] [Related]
10. Optimizing RNA/ENA chimeric antisense oligonucleotides using in vitro splicing.
Takeshima Y; Yagi M; Matsuo M
Methods Mol Biol; 2012; 867():131-41. PubMed ID: 22454059
[TBL] [Abstract][Full Text] [Related]
11. Making antisense of splicing.
Garcia-Blanco MA
Curr Opin Mol Ther; 2005 Oct; 7(5):476-82. PubMed ID: 16248283
[TBL] [Abstract][Full Text] [Related]
12. A neuron-specific splicing switch mediated by an array of pre-mRNA repressor sites: evidence of a regulatory role for the polypyrimidine tract binding protein and a brain-specific PTB counterpart.
Ashiya M; Grabowski PJ
RNA; 1997 Sep; 3(9):996-1015. PubMed ID: 9292499
[TBL] [Abstract][Full Text] [Related]
13. Up-regulation of luciferase gene expression with antisense oligonucleotides: implications and applications in functional assay development.
Kang SH; Cho MJ; Kole R
Biochemistry; 1998 May; 37(18):6235-9. PubMed ID: 9572837
[TBL] [Abstract][Full Text] [Related]
14. In vitro correction of a pseudoexon-generating deep intronic mutation in LGMD2A by antisense oligonucleotides and modified small nuclear RNAs.
Blázquez L; Aiastui A; Goicoechea M; Martins de Araujo M; Avril A; Beley C; García L; Valcárcel J; Fortes P; López de Munain A
Hum Mutat; 2013 Oct; 34(10):1387-95. PubMed ID: 23864287
[TBL] [Abstract][Full Text] [Related]
15. Antisense oligonucleotide-mediated exon skipping of CHRNA1 pre-mRNA as potential therapy for Congenital Myasthenic Syndromes.
Tei S; Ishii HT; Mitsuhashi H; Ishiura S
Biochem Biophys Res Commun; 2015 Jun; 461(3):481-6. PubMed ID: 25888793
[TBL] [Abstract][Full Text] [Related]
16. Overview on AON design.
Aartsma-Rus A
Methods Mol Biol; 2012; 867():117-29. PubMed ID: 22454058
[TBL] [Abstract][Full Text] [Related]
17. Modulation of in vitro splicing of the upstream intron by modifying an intra-exon sequence which is deleted from the dystrophin gene in dystrophin Kobe.
Takeshima Y; Nishio H; Sakamoto H; Nakamura H; Matsuo M
J Clin Invest; 1995 Feb; 95(2):515-20. PubMed ID: 7860733
[TBL] [Abstract][Full Text] [Related]
18. Modification of pre-mRNA splicing by antisense oligonucleotides.
Kole R
Acta Biochim Pol; 1997; 44(2):231-7. PubMed ID: 9360712
[TBL] [Abstract][Full Text] [Related]
19. Antisense properties of tricyclo-DNA.
Renneberg D; Bouliong E; Reber U; Schümperli D; Leumann CJ
Nucleic Acids Res; 2002 Jul; 30(13):2751-7. PubMed ID: 12087157
[TBL] [Abstract][Full Text] [Related]
20. Splicing by exon exclusion impaired by artificial box c/d RNA targeted to branch-point adenosine.
Semenov DV; Vratskih OV; Kuligina EV; Richter VA
Ann N Y Acad Sci; 2008 Aug; 1137():119-24. PubMed ID: 18837934
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
